Grant: CIHR Fellowship
McGill University
$135,000.00
Role of mTORC1 downstream pathway in regulation of breast cancer tumorigenesis.
FY 2012-13
Summary
Breast cancer is a malignant disease with high prevalence in Canadian population. Across the country there will be an estimated 23000 new cases of breast cancer and 5100 cases of breast cancer-related death in 2012. This disease is characterized by uncontrolled growth and proliferation of the previously normal cells which eventually may invade the surrounding tissues and progress to metastasis. Unfortunately, we still do not fully understand how the normal mechanisms which control the processes of cell growth and proliferation go awry in cancer cells. The mTORC1 complex is known to be one of the major suspects and we have some promising new data that suppression of this complex may help in treatment of breast cancer. Also by using cell culture methods we have recently discovered that two master regulator of protein synthesis, called 4E-BPs and S6Ks are mainly responsible for the effect of mTORC1 on cell growth and proliferation. However, it is not clear whether the role of 4E-BPs and S6Ks in regulation of cell growth and proliferation also has any actual significance in development of breast cancer in the tissue. In addition, the molecular mediators downstream of 4E-BPs and S6Ks and their significance in breast cancer biology are not fully understood either. This project therefore aims to use a comprehensive approach to fully delineate the role of 4E-BPs and S6Ks in breast cancer development and determine their downstream mediators and effectors. By understanding this pathway, we will be able to design novel therapeutic approaches for treatment of breast cancer.
Department
Program
CIHR Fellowship
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
268776
Name
Jafarnejad Shourkaei Seyed Mehdi
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of mTORC1 downstream pathway in regulation of breast cancer tumorigenesis.
Programtype2
Fellowship Programs
Orgnameinp2
McGill University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Cancer; Cell Biology; Genetics; Molecular Biology
Abstract
Breast cancer is a malignant disease with high prevalence in Canadian population. Across the country there will be an estimated 23000 new cases of breast cancer and 5100 cases of breast cancer-related death in 2012. This disease is characterized by uncontrolled growth and proliferation of the previously normal cells which eventually may invade the surrounding tissues and progress to metastasis. Unfortunately, we still do not fully understand how the normal mechanisms which control the processes of cell growth and proliferation go awry in cancer cells. The mTORC1 complex is known to be one of the major suspects and we have some promising new data that suppression of this complex may help in treatment of breast cancer. Also by using cell culture methods we have recently discovered that two master regulator of protein synthesis, called 4E-BPs and S6Ks are mainly responsible for the effect of mTORC1 on cell growth and proliferation. However, it is not clear whether the role of 4E-BPs and S6Ks in regulation of cell growth and proliferation also has any actual significance in development of breast cancer in the tissue. In addition, the molecular mediators downstream of 4E-BPs and S6Ks and their significance in breast cancer biology are not fully understood either. This project therefore aims to use a comprehensive approach to fully delineate the role of 4E-BPs and S6Ks in breast cancer development and determine their downstream mediators and effectors. By understanding this pathway, we will be able to design novel therapeutic approaches for treatment of breast cancer.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Jafarnejad Shourkaei, Seyed Mehdi
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~